1. Home
  2. GEL vs BCRX Comparison

GEL vs BCRX Comparison

Compare GEL & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEL
  • BCRX
  • Stock Information
  • Founded
  • GEL 1996
  • BCRX 1986
  • Country
  • GEL United States
  • BCRX United States
  • Employees
  • GEL N/A
  • BCRX N/A
  • Industry
  • GEL Oil Refining/Marketing
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GEL Energy
  • BCRX Health Care
  • Exchange
  • GEL Nasdaq
  • BCRX Nasdaq
  • Market Cap
  • GEL 1.6B
  • BCRX 1.7B
  • IPO Year
  • GEL 1996
  • BCRX 1994
  • Fundamental
  • Price
  • GEL $16.63
  • BCRX $10.09
  • Analyst Decision
  • GEL Buy
  • BCRX Buy
  • Analyst Count
  • GEL 3
  • BCRX 8
  • Target Price
  • GEL $16.50
  • BCRX $16.75
  • AVG Volume (30 Days)
  • GEL 519.6K
  • BCRX 3.5M
  • Earning Date
  • GEL 07-31-2025
  • BCRX 08-04-2025
  • Dividend Yield
  • GEL 3.97%
  • BCRX N/A
  • EPS Growth
  • GEL N/A
  • BCRX N/A
  • EPS
  • GEL N/A
  • BCRX N/A
  • Revenue
  • GEL $2,930,080,000.00
  • BCRX $503,485,000.00
  • Revenue This Year
  • GEL N/A
  • BCRX $39.04
  • Revenue Next Year
  • GEL $5.69
  • BCRX $13.26
  • P/E Ratio
  • GEL N/A
  • BCRX N/A
  • Revenue Growth
  • GEL 3.87
  • BCRX 41.67
  • 52 Week Low
  • GEL $9.86
  • BCRX $5.92
  • 52 Week High
  • GEL $16.96
  • BCRX $11.31
  • Technical
  • Relative Strength Index (RSI)
  • GEL 62.67
  • BCRX 43.54
  • Support Level
  • GEL $16.15
  • BCRX $9.84
  • Resistance Level
  • GEL $16.96
  • BCRX $10.47
  • Average True Range (ATR)
  • GEL 0.43
  • BCRX 0.34
  • MACD
  • GEL -0.02
  • BCRX -0.19
  • Stochastic Oscillator
  • GEL 79.88
  • BCRX 8.16

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a limited partnership company that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: